MUCORMYCOSIS; PULMONARY (ETIOLOGY)

Clinical trials for MUCORMYCOSIS; PULMONARY (ETIOLOGY) explained in plain language.

Never miss a new study

Get alerted when new MUCORMYCOSIS; PULMONARY (ETIOLOGY) trials appear

Sign up with your email to follow new studies for MUCORMYCOSIS; PULMONARY (ETIOLOGY), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Completed 1

New hope for deadly lung fungus: cheaper pill may replace toxic IV

Disease control Completed

This study tested two medicines for a severe lung infection called pulmonary mucormycosis, which has a high death rate. The standard treatment, amphotericin B, is given through an IV and can cause serious side effects. The study compared it to posaconazole, a pill that may be eas…

Matched conditions: MUCORMYCOSIS; PULMONARY (ETIOLOGY)

Phase: PHASE2 • Sponsor: Post Graduate Institute of Medical Education and Research, Chandigarh • Aim: Disease control

Last updated May 26, 2026 12:07 UTC

MUCORMYCOSIS; PULMONARY (ETIOLOGY)

Get alerted when new MUCORMYCOSIS; PULMONARY (ETIOLOGY) trials appear

New hope for deadly lung fungus: cheaper pill may replace toxic IV